Markus D Siegelin

7PUBLICATIONS
53CO-AUTHORS
Predictive and prognostic markersGene and molecular therapyMedical biochemistry - lipidsMolecular targetsGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 27, 2024
A cell state-specific metabolic vulnerability to GPX4-dependent ferroptosis in glioblastoma.

Matei A Banu, Athanassios Dovas, Michael G Argenziano

|Aug 23, 2023
MGMT Promoter Methylation Predicts Overall Survival after Chemotherapy for 1p/19q-Codeleted Gliomas.

Connor J Kinslow, Ali I Rae, Kekoa Taparra

|Mar 02, 2023
Dietary restriction of cysteine and methionine sensitizes gliomas to ferroptosis and induces alterations in energetic metabolism.

Pavan S Upadhyayula, Dominique M Higgins, Angeliki Mela

|Apr 13, 2022
Induction of Synthetic Lethality by Activation of Mitochondrial ClpP and Inhibition of HDAC1/2 in Glioblastoma.

Trang T T Nguyen, Enyuan Shang, Salveena Schiffgens

|Sep 02, 2021
Aurora kinase A inhibition reverses the Warburg effect and elicits unique metabolic vulnerabilities in glioblastoma.

Trang T T Nguyen, Enyuan Shang, Chang Shu

|Jun 10, 2020
Bi-allelic missense disease-causing variants in RPL3L associate neonatal dilated cardiomyopathy with muscle-specific ribosome biogenesis.

Mythily Ganapathi, Loukas Argyriou, Francisco Martínez-Azorín

Pageof 2